AI Innovations in Early Detection of Myopic Maculopathy: Protecting Millions from Vision Loss

The Rising Threat of Myopia and Myopic Maculopathy

Myopia, or nearsightedness, is becoming increasingly prevalent worldwide, especially among children. Experts predict that by 2050, approximately 50% of the global population will be affected by myopia 1

1

2

2

3

3

. This surge is partly attributed to increased "near work" activities, such as prolonged use of smartphones and computer screens.

While many manage myopia with corrective lenses, some develop a more severe condition called myopic maculopathy. This occurs when the macula, responsible for sharp central vision, is stretched and damaged due to the eye's elongation. In 2015, myopic maculopathy caused visual impairment in 10 million people, with projections suggesting that by 2050, over 55 million could experience vision loss and about 18 million could become blind from this condition 1

1

2

2

3

3

.

AI-Powered Solutions for Early Detection

Researchers at Arizona State University's School of Computing and Augmented Intelligence are developing innovative diagnostic tools using artificial intelligence (AI) to enhance screening for myopic maculopathy 1

1

2

2

3

3

. Led by Professor Yalin Wang, the team is leveraging AI to improve diagnosis accuracy, especially in the disease's earliest stages.

The research team participated in a challenge issued by the Medical Image Computing and Computer Assisted Intervention (MICCAI) Society in 2023, aimed at improving computer-aided screening systems for retinal images 1

1

2

2

3

3

. Their work focused on three main areas:

1. Disease Classification: The team developed new AI algorithms called NN-MobileNet to effectively analyze retinal images and predict the correct classification of myopic maculopathy severity 1

   1

   2

   2

   3

   3

   .

2. Spherical Equivalent Prediction: Using deep neural networks, the researchers created algorithms to more accurately predict the spherical equivalent in retinal scans, crucial for prescribing corrective lenses 1

   1

   2

   2

   3

   3

   .

3. Collaborative Research: Wang and his team collaborated with other winning teams from the MICCAI challenge, publishing their collective findings in JAMA Ophthalmology 1

   1

   2

   2

   3

   3

   4

   4

   .

Global Impact and Health Equity

The development of AI-powered diagnostic tools has significant implications for global health equity. Wang emphasizes that this technology could particularly benefit people in rural areas and developing countries, where access to sophisticated imaging devices and specialized physicians is limited 1

1

2

2

3

3

.

Ross Maciejewski, director of the School of Computing and Augmented Intelligence, highlights the importance of this research in addressing the increasing prevalence of myopia and myopic maculopathy 1

1

2

2

3

3

. The innovative use of AI in this field could potentially revolutionize early detection and treatment strategies, ultimately preventing vision loss for millions worldwide.

Future Prospects

As AI technology continues to advance, its application in ophthalmology holds promise for more accurate, efficient, and accessible diagnostic tools. This could lead to earlier interventions, such as prescribing special contact lenses or eye drops to slow disease progression, particularly crucial for children 1

1

2

2

3

3

. The ongoing research and collaboration in this field are paving the way for improved eye care and reduced vision loss on a global scale.